Chemomab Therapeutics Ltd. American Depositary Shares is an innovative biopharmaceutical company specializing in the development and commercialization of targeted immunotherapies for the treatment of cancer. With a strong focus on precision medicine and groundbreaking research, Chemomab is poised to revolutionize the way cancer is diagnosed and treated.
